NEOS Investment Management LLC Takes $48.75 Million Position in Astera Labs, Inc. $ALAB

NEOS Investment Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the second quarter, HoldingsChannel reports. The fund bought 100,936 shares of the company’s stock, valued at approximately $48,754,000.

A number of other institutional investors have also modified their holdings of the business. Greenleaf Trust raised its position in Astera Labs by 1.8% in the 2nd quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock valued at $966,000 after purchasing an additional 36 shares during the last quarter. Glenmede Trust Co. NA increased its stake in Astera Labs by 2.7% in the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the period. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs in the second quarter valued at $25,000. Lido Advisors LLC raised its holdings in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after buying an additional 57 shares during the last quarter. Finally, Archer Investment Corp purchased a new stake in shares of Astera Labs in the second quarter valued at about $30,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $274.96, for a total value of $963,734.80. Following the completion of the sale, the director directly owned 50,456 shares of the company’s stock, valued at $13,873,381.76. This represents a 6.50% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 592,244 shares of company stock worth $209,729,973 in the last three months. Company insiders own 10.40% of the company’s stock.

Astera Labs Stock Performance

ALAB stock opened at $282.82 on Friday. The stock has a market capitalization of $49.07 billion, a PE ratio of 140.01 and a beta of 3.77. The company has a fifty day moving average of $332.37 and a 200-day moving average of $253.97. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48.

Astera Labs (NASDAQ:ALABGet Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business’s revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for robust third-quarter growth and reinforcing the company’s AI data-center expansion story. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
  • Positive Sentiment: Astera’s role in supplying high-speed connectivity for large-scale AI data centers remains a key investment attraction, although NVIDIA retains a broader competitive advantage through its chips and software ecosystem. Better Artificial Intelligence Stock: Astera Labs vs. NVIDIA
  • Neutral Sentiment: The stock remains under pressure following its latest earnings report, declining 13.9% since results were released and 24% over the past month. The decline highlights elevated expectations and uncertainty about the next phase of growth. Why Is Astera Labs, Inc. (ALAB) Down 13.9% Since Last Earnings Report?
  • Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his position by 41.9%. Director Stefan Dyckerhoff also sold a combined 12,499 shares worth about $3.4 million. Both transactions were conducted under pre-arranged Rule 10b5-1 trading plans, which may lessen their signal as discretionary insider bearishness but could still weigh on sentiment and add selling supply. SEC Form 4 Filing

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Astera Labs in a report on Tuesday, August 18th. Morgan Stanley upped their price objective on Astera Labs to $335.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Evercore reaffirmed an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a research report on Tuesday, May 19th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Finally, Bank of America boosted their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a report on Tuesday, June 23rd. One research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $348.33.

Read Our Latest Stock Analysis on ALAB

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Stories

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.